{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T15:55:53Z","timestamp":1765727753264},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Peripheral T-cell lymphomas not otherwise specified are generally considered aggressive non-Hodgkin lymphomas, because of poor natural outcome and response to therapy. They show a complex karyotype without any specific genetic hallmark. We report a case of peripheral T-cell lymphoma not otherwise specified with heterogeneous nuclear Cyclin D1 immunohistochemical overexpression, due to gene copy gain, a phenomenon similar to that observed in Mantle Cell Lymphoma characterized by t(11;14)(q13;q32). In this case report we underline the diagnostic pitfall rapresented by Cyclin D1 immunoistochemical overexpression in a T-cell lymphoma. Several pitfalls could lead to misinterpretation of diagnosis, therefore, we underlined the need to integrate the classical histology and immunohistochemistry with molecular tests as clonality or Fluorescence in situ hybridization.<\/jats:p>\n          <jats:p>\n            <jats:bold>Virtual slide<\/jats:bold>\n          <\/jats:p>\n          <jats:p>The virtual slides for this article can be found here: http:\/\/www.diagnosticpathology.diagnomx.eu\/vs\/1117747619703769<\/jats:p>","DOI":"10.1186\/1746-1596-7-79","type":"journal-article","created":{"date-parts":[[2012,7,6]],"date-time":"2012-07-06T12:14:33Z","timestamp":1341576873000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Peripheral T-cell Lymphoma with Cyclin D1 overexpression: a case report"],"prefix":"10.1186","volume":"7","author":[{"given":"Gabriella","family":"Aquino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato","family":"Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fioravante","family":"Ronconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"Anniciello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annarosaria","family":"De Chiara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Panico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,7,6]]},"reference":[{"key":"577_CR1","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose J, Armitage J, Weisenburger D: International peripheral Tcell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008, 26: 4124-4130.","journal-title":"J Clin Oncol"},{"key":"577_CR2","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/annonc\/mdf033","volume":"13","author":"T R\u00fcdiger","year":"2002","unstructured":"R\u00fcdiger T, Weisenburger DD, Anderson JR, Armitage JO, Diebold J, MacLennan KA, Nathwani BN, Ullrich F, M\u00fcller-Hermelink HK, Non-Hodgkin's Lymphoma Classification Project: Non-Hodgkin's Lymphoma Classification Project: Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non- Hodgkin\u2019s Lymphoma Classification Project. Ann Oncol. 2002, 13: 140-149. 10.1093\/annonc\/mdf033.","journal-title":"Ann Oncol"},{"key":"577_CR3","doi-asserted-by":"publisher","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","volume":"15","author":"KJ Savage","year":"2008","unstructured":"Savage KJ, Harris NL, Vose JM, Ullrich F, Jaffe ES, Connors JM, Rimsza L, Pileri SA, Chhanabhai M, Gascoyne RD, Armitage JO, Weisenburger DD, International Peripheral T-Cell Lymphoma Project: International Peripheral T-Cell Lymphoma Project: ALK\u2009\u2212\u2009anaplastic largecell lymphoma is clinically and immunophenotypically different from both ALK\u2009+\u2009ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T Cell Lymphoma Project. Blood. 2008, 15: 5496-5504.","journal-title":"Blood"},{"key":"577_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1023\/A:1008384631177","volume":"1","author":"R Willemze","year":"2000","unstructured":"Willemze R, Meijer CJ: EORTC classification for primary cutaneous lymphomas: a comparison with the R.E.A.L. Classification and the proposed WHO Classification. Ann Oncol. 2000, 1: 11-15.","journal-title":"Ann Oncol"},{"key":"577_CR5","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1126\/science.8122112","volume":"263","author":"SW Morris","year":"1994","unstructured":"Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL, Look AT: Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin\u2019s lymphoma. Science. 1994, 263: 1281-1284. 10.1126\/science.8122112.","journal-title":"Science"},{"key":"577_CR6","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood.V89.3.948","volume":"89","author":"K Tsukasaki","year":"1997","unstructured":"Tsukasaki K, Tsushima H, Yamamura M, Hata T, Murata K, Maeda T, Atogami S, Sohda H, Momita S, Ideda S, Katamine S, Yamada Y, Kamihira S, Tomonaga M: Integration patterns of HTLV-I provirus in relation to the clinical course of ATL: frequent clonal change at crisis from indolent disease. Blood. 1997, 89: 948-956.","journal-title":"Blood"},{"key":"577_CR7","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s11899-010-0062-x","volume":"5","author":"PP Piccaluga","year":"2010","unstructured":"Piccaluga PP, Agostinelli C, Gazzola A, Mannu C, Bacci F, Sabattini E, Pileri SA: Prognostic markers in peripheral T-cell lymphoma. Curr Hematol Malig Rep. 2010, 5: 222-228. 10.1007\/s11899-010-0062-x.","journal-title":"Curr Hematol Malig Rep"},{"key":"577_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nrc2771","volume":"10","author":"T Santarius","year":"2010","unstructured":"Santarius T, Shipley J, Brewer D, Stratton MR, Cooper CS: A census of amplified and overexpressed human cancer genes. Nat Rev Cancer. 2010, 10: 59-64. 10.1038\/nrc2771.","journal-title":"Nat Rev Cancer"},{"key":"577_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/hon.767","volume":"24","author":"F Bertoni","year":"2006","unstructured":"Bertoni F, Rinaldi A, Zucca E, Cavalli F: Update on the molecular biology of mantle cell lymphoma. Hematol Oncol. 2006, 24: 22-27. 10.1002\/hon.767.","journal-title":"Hematol Oncol"},{"key":"577_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1053\/hupa.2002.30221","volume":"33","author":"SH Swerdlow","year":"2002","unstructured":"Swerdlow SH, Williams ME: From centrocytic to mantle cell lymphoma: a clinicopathologic and molecular review of 3 decades. Hum Pathol. 2002, 33: 7-20. 10.1053\/hupa.2002.30221.","journal-title":"Hum Pathol"},{"key":"577_CR11","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/nature08822","volume":"18","author":"R Beroukhim","year":"2010","unstructured":"Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, Barretina J, Boehm JS, Dobson J, Urashima M, Mc Henry KT, Pinchback RM, Ligon AH, Cho YJ, Haery L, Greulich H, Reich M, Winckler W, Lawrence MS, Weir BA, Tanaka KE, Chiang DY, Bass AJ, Loo A, Hoffman C, Prensner J, Liefeld T, Gao Q, Yecies D, Signoretti S, Maher E, Kaye FJ, Sasaki H, Tepper JE, Fletcher JA, Tabernero J, Baselga J, Tsao MS, Demichelis F, Rubin MA, Janne PA, Daly MJ, Nucera C, Levine RL, Ebert BL, Gabriel S, Rustgi AK, Antonescu CR, Ladanyi M, Letai A, Garraway LA, Loda M, Beer DG, True LD, Okamoto A, Pomeroy SL, Singer S, Golub TR, Lander ES, Getz G, Sellers WR, Meyerson M: The landscape of somatic copy-number alteration across human cancers. Nature. 2010, 18: 899-905.","journal-title":"Nature"},{"key":"577_CR12","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1038\/sj.jid.5700224","volume":"126","author":"X Mao","year":"2006","unstructured":"Mao X, Orchard G, Vonderheid EC, Nowell PC, Bagot M, Bensussan A, Russell-Jones R, Young BD, Whittaker SJ: Heterogeneous abnormalities of CCND1 and RB1 in primary cutaneous T-Cell lymphomas suggesting impaired cell cycle control in disease pathogenesis. J Invest Dermatol. 2006, 126: 1388-1395. 10.1038\/sj.jid.5700224.","journal-title":"J Invest Dermatol"},{"key":"577_CR13","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1023\/A:1008265532487","volume":"9","author":"JR Anderson","year":"1998","unstructured":"Anderson JR, Armitage JO, Weisenburger DD: Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project. Ann Oncol. 1998, 9: 717-720. 10.1023\/A:1008265532487.","journal-title":"Ann Oncol"},{"key":"577_CR14","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1200\/JCO.2006.09.4474","volume":"25","author":"M Cuadros","year":"2007","unstructured":"Cuadros M, Dave SS, Jaffe ES, Honrado E, Milne R, Alves J, Rodr\u00edguez J, Zajac M, Benitez J, Staudt LM, Martinez-Delgado B: Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas. In this article, the authors provided evidence of the prognostic relevance of proliferation rate in PTCL\/NOS, based on gene expression data. J Clin Oncol. 2007, 25: 3321-3329. 10.1200\/JCO.2006.09.4474.","journal-title":"J Clin Oncol"},{"key":"577_CR15","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/modpathol.3800434","volume":"18","author":"CP Hans","year":"2005","unstructured":"Hans CP, Weisenburger DD, Greiner TC, Chan WC, Aoun P, Cochran GT, Pan Z, Smith LM, Lynch JC, Bociek RG, Bierman PJ, Vose JM, Armitage JO: Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma. Mod Pathol. 2005, 18: 1377-1384. 10.1038\/modpathol.3800434.","journal-title":"Mod Pathol"},{"key":"577_CR16","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1309\/8KF0-0Y0C-2F4L-UHXL","volume":"115","author":"MB Moller","year":"2001","unstructured":"Moller MB, Nielsen O, Pedersen NT: Cyclin D3 expression in non-Hodgkin lymphoma. Correlation with other cell cycle regulators and clinical features. Am J Clin Pathol. 2001, 115: 404-412. 10.1309\/8KF0-0Y0C-2F4L-UHXL.","journal-title":"Am J Clin Pathol"},{"key":"577_CR17","first-page":"377","volume":"16","author":"P Kanavaros","year":"2001","unstructured":"Kanavaros P, Bai M, Stefanaki K, Poussias G, Rontogianni D, Zioga E, Gorgoulis V, Agnantis NJ: Immunohistochemical expression of the p53, mdm2, p21\/Waf-1, Rb, p16, Ki67, cyclin D1, cyclin A and cyclin B1 proteins and apoptotic index in T-cell lymphomas. Histol Histopathol. 2001, 16: 377-386.","journal-title":"Histol Histopathol"},{"key":"577_CR18","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nrc2230","volume":"7","author":"P Jares","year":"2007","unstructured":"Jares P, Colomer D, Campo E: Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nat Rev Cancer. 2007, 7: 750-762. 10.1038\/nrc2230.","journal-title":"Nat Rev Cancer"},{"key":"577_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0169-5002(01)00225-2","volume":"34","author":"M Jin","year":"2001","unstructured":"Jin M, Inoue S, Umemura T, Moriya J, Arakawa M, Nagashima K, Kato H: Cyclin D1, p16 and retinoblastoma gene product expression as a predictor for prognosis in non-small cell lung cancer at stages I and II. Lung Cancer. 2001, 34: 207-218. 10.1016\/S0169-5002(01)00225-2.","journal-title":"Lung Cancer"},{"key":"577_CR20","first-page":"1812","volume":"54","author":"C Gillett","year":"1994","unstructured":"Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D, Peters G: Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res. 1994, 54: 1812-1817.","journal-title":"Cancer Res"},{"key":"577_CR21","first-page":"949","volume":"15","author":"J Bartkova","year":"1995","unstructured":"Bartkova J, Lukas J, M\u00fcller H, Strauss M, Gusterson B, Bartek J: Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res. 1995, 15: 949-956.","journal-title":"Cancer Res"},{"key":"577_CR22","first-page":"261","volume":"16","author":"A Shamma","year":"2000","unstructured":"Shamma A, Doki Y, Shiozaki H, Tsujinaka T, Yamamoto M, Inoue M, Yano M, Monden M: Cyclin D1 overexpression in esophageal dysplasia: a possible biomarker for carcinogenesis of esophageal squamous cell carcinoma. Int J Oncol. 2000, 16: 261-266.","journal-title":"Int J Oncol"},{"key":"577_CR23","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/(SICI)1096-9896(199612)180:4<395::AID-PATH688>3.0.CO;2-C","volume":"180","author":"JL Mate","year":"1996","unstructured":"Mate JL, Ariza A, Aracil C, L\u00f3pez D, Isamat M, P\u00e9rez-Piteira J, Navas-Palacios JJ: Cyclin D1 overexpression in non-small cell lung carcinoma: Correlation with Ki-67 labeling index and poor cytoplasmic differentiation. J Pathol. 1996, 180: 395-399. 10.1002\/(SICI)1096-9896(199612)180:4<395::AID-PATH688>3.0.CO;2-C.","journal-title":"J Pathol"},{"key":"577_CR24","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/S0046-8177(98)90244-1","volume":"29","author":"S Staibano","year":"1998","unstructured":"Staibano S, Mignogna MD, Lo Muzio L, Di Alberti L, Di Natale E, Lucariello A, Mezza E, Bucci E, DeRosa G: Over expression of Cyclin D1, Bcl-2 and bax proteins, proliferating cell nuclear antigen (PCNA), and DNA-Ploidy in squamous cell carcinoma of the oral cavity. Hum Pathol. 1998, 29: 1189-1195. 10.1016\/S0046-8177(98)90244-1.","journal-title":"Hum Pathol"},{"key":"577_CR25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1034\/j.1600-0714.2000.290404.x","volume":"29","author":"KY Lam","year":"2000","unstructured":"Lam KY, Ng IO, Yuen AP, Kwong DL, Wei W: Cyclin D1 expression in oral squamous cell carcinomas: Clinicopathological relevance and correlation with p53 expression. J Oral Pathol Med. 2000, 29: 167-172. 10.1034\/j.1600-0714.2000.290404.x.","journal-title":"J Oral Pathol Med"},{"key":"577_CR26","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.oraloncology.2003.08.021","volume":"40","author":"A Etges","year":"2004","unstructured":"Etges A, Nunes FD, Reibero KC, Ara\u00fajo VC: Immunohistochemical expression of retinoblastoma pathway proteins in normal salivary glands and in tumors of salivary glands. Oral Oncol. 2004, 40: 326-331. 10.1016\/j.oraloncology.2003.08.021.","journal-title":"Oral Oncol"},{"key":"577_CR27","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/(SICI)1097-0347(200005)22:3<234::AID-HED5>3.0.CO;2-3","volume":"22","author":"P Capaccio","year":"2000","unstructured":"Capaccio P, Pruneri G, Carboni N, Pagliari AV, Quatela M, Cesana BM, Pignataro L: Cyclin D1 expression is predictive of occult metastases in head and neck cancer patients with clinically negative cervical lymph nodes. Head Neck. 2000, 22: 234-240. 10.1002\/(SICI)1097-0347(200005)22:3<234::AID-HED5>3.0.CO;2-3.","journal-title":"Head Neck"},{"key":"577_CR28","first-page":"409","volume":"9","author":"R Naidu","year":"2002","unstructured":"Naidu R, Wahab NA, Yadav MM, Kutty MK: Expression and amplification of cyclin D1 in primary breast carcinomas: relationship with histopathological types and clinico-pathological parameters. Oncol Rep. 2002, 9: 409-416.","journal-title":"Oncol Rep"},{"key":"577_CR29","first-page":"803","volume":"13","author":"J Zhu","year":"2010","unstructured":"Zhu J, Yu L, Zhan P, Song Y, Wang Q: The relationships between cyclin D1 expression and prognosis of non-small cell lung cancer. Zhongguo Fei Ai Za Zhi. 2010, 13: 803-808.","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"577_CR30","volume-title":"Cancer","author":"W Cao","year":"2010","unstructured":"Cao W, Feng Z, Cui Z, Zhang C, Sun Z, Mao L, Chen W: Up-regulation of enhancer of zeste homolog 2 is associated positively with cyclin D1 overexpression and poor clinical outcome in head and neck squamous cell carcinoma. Cancer. 2010, 10.1002\/cncr.26575."},{"key":"577_CR31","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00432-004-0661-9","volume":"131","author":"D Dworakowska","year":"2005","unstructured":"Dworakowska D, Jassem E, Jassem J, Boltze C, Wiedorn KH, Dworakowski R, Skokowski J, Ja\u015bkiewicz K, Czestochowska E: Prognostic value of cyclin D1 overexpression in correlation with pRb and p53 status in non-small cell lung cancer (NSCLC). J Cancer Res Clin Oncol. 2005, 131: 479-485. 10.1007\/s00432-004-0661-9.","journal-title":"J Cancer Res Clin Oncol"},{"key":"577_CR32","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/10245330600841097","volume":"11","author":"S Aref","year":"2006","unstructured":"Aref S, Mossad Y, El-Khodary T, Awad M, El-Shahat: Cyclin Dl expression in B-cell non Hodgkin lymphoma. Hematology. 2006, 11: 365-370. 10.1080\/10245330600841097.","journal-title":"Hematology"},{"key":"577_CR33","first-page":"927","volume":"10","author":"MA Vasef","year":"1997","unstructured":"Vasef MA, Medeiros LJ, Yospur LS, Sun NC, McCourty A, Brynes RK: Cyclin D1 protein in multiple myeloma and plasmacytoma: an immunohistochemical study using fixed, paraffin-embedded tissue sections. Mod Pathol. 1997, 10: 927-932.","journal-title":"Mod Pathol"},{"key":"577_CR34","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.1038\/sj.onc.1209474","volume":"25","author":"B Burnworth","year":"2006","unstructured":"Burnworth B, Popp S, Stark HJ, Steinkraus V, Br\u00f6cker EB, Hartschuh W, Birek C, Boukamp P: Gain of 11q\/cyclin D1 overexpression is an essential early step in skin cancer development and causes abnormal tissue organization and differentiation. Oncogene. 2006, 25: 4399-4412. 10.1038\/sj.onc.1209474.","journal-title":"Oncogene"},{"key":"577_CR35","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1038\/sj.onc.1202153","volume":"17","author":"JG Izzo","year":"1998","unstructured":"Izzo JG, Papadimitrakopoulou VA, Li XQ, Ibarguen H, Lee JS, Ro JY, El-Naggar A, Hong WK, Hittelman WN: Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification. Oncogene. 1998, 17: 2313-2322. 10.1038\/sj.onc.1202153.","journal-title":"Oncogene"},{"key":"577_CR36","first-page":"2133","volume":"5","author":"NA Hibberts","year":"1999","unstructured":"Hibberts NA, Simpson DJ, Bicknell JE, Broome JC, Hoban PR, Clayton RN, Farrell WE: Analysis of cyclin D1 (CCND1) allelic imbalance and overexpression in sporadic human pituitary tumors. Clin Cancer Res. 1999, 5: 2133-2139.","journal-title":"Clin Cancer Res"},{"key":"577_CR37","first-page":"1155","volume":"2","author":"H Shinozaki","year":"1996","unstructured":"Shinozaki H, Ozawa S, Ando N, Tsuruta H, Terada M, Ueda M, Kitajima M: Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information. Clin Cancer Res. 1996, 2: 1155-1161.","journal-title":"Clin Cancer Res"},{"key":"577_CR38","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1101\/gad.854900","volume":"14","author":"JR Alt","year":"2000","unstructured":"Alt JR, Cleveland JL, Hannink M, Diehl JA: Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes Dev. 2000, 14: 3102-3114. 10.1101\/gad.854900.","journal-title":"Genes Dev"},{"key":"577_CR39","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/sj.onc.1209371","volume":"25","author":"KE Knudsen","year":"2006","unstructured":"Knudsen KE, Alan Diehl J, Haiman CA, Knudsen ES: Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene. 2006, 25: 1620-1628. 10.1038\/sj.onc.1209371.","journal-title":"Oncogene"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1746-1596-7-79.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T19:52:02Z","timestamp":1630525922000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/1746-1596-7-79"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,6]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["577"],"URL":"https:\/\/doi.org\/10.1186\/1746-1596-7-79","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,6]]},"assertion":[{"value":"28 March 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"79"}}